344 results on '"Elley, C. Raina"'
Search Results
2. The association between church attendance and obesity-related lifestyle behaviours among New Zealand adolescents from different Pacific Island ethnic groups
- Author
-
Dewes, Ofa, Scragg, Robert, and Elley, C. Raina
- Published
- 2013
3. Effectiveness of simulated clinical teaching in general practice : randomised controlled trial
- Author
-
Elley, C. Raina
- Published
- 2012
4. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
- Author
-
Astor, Brad, Appel, Lawrence J, Levin, Adeera, Tang, Mila, Djurdjev, Ognjenka, Navaneethan, Sankar D, Jolly, Stacey E, Schold, Jesse D, Nally, Joseph V, Wheeler, David C, Emberson, Jonathan, Townend, John, Landray, Martin, Feldman, Harold I, Hsu, Chi-yuan, Lash, James P, Kalra, Philip A, Ritchie, James P, Maharajan, Raman, Middleton, Rachel J, O’Donoghue, Donal J, Eckardt, Kai-Uwe, Schneider, Markus P, Köttgen, Anna, Kronenberg, Florian, Bärthlein, Barbara, Chang, Alex R, Green, Jamie A, Kirchner, H Lester, Ho, Kevin, Marks, Angharad, Black, Corri, Prescott, Gordon J, Fluck, Nick, Nakayama, Masaaki, Miyazaki, Mariko, Yamamoto, Tae, Yamada, Wang, Angela Yee-Moon, Cheung, Sharon, Wong, Sharon, Chu, Jessie, Wu, Henry, Garg, Amit X, McArthur, Eric, Nash, Danielle M, Shalev, Varda, Chodick, Gabriel, Blankestijn, Peter J, Wetzels, Jack FM, van Zuilen, Arjan D, van den Brand, Jan A, Levey, Andrew S, Inker, Lesley A, Sarnak, Mark J, Tighiouart, Hocine, Zhang, Haitao, Stengel, Benedicte, Metzger, Marie, Flamant, Martin, Houillier, Pascal, Haymann, Jean-Philippe, Rios, Pablo G, Mazzuchi, Nelson, Gadola, Liliana, Lamadrid, Verónica, Sola, Laura, Collins, John F, Elley, C Raina, Kenealy, Timothy, Moranne, Olivier, Couchoud, Cecile, Vigneau, Cecile, Brunskill, Nigel J, Major, Rupert W, Shepherd, David, Medcalf, James F, Kovesdy, Csaba P, Kalantar-Zadeh, Kamyar, Molnar, Miklos Z, Sumida, Keiichi, Potukuchi, Praveen K, Heerspink, Hiddo JL, de Zeeuw, Dick, Brenner, Barry, Carrero, Juan Jesus, Gasparini, Alessandro, Qureshi, Abdul Rashid, Elinder, Carl-Gustaf, Visseren, Frank LJ, van der Graaf, Yolanda, Evans, Marie, Stendahl, Maria, Schön, Staffan, Segelmark, Mårten, Prütz, Karl-Göran, Naimark, David M, Tangri, Navdeep, and Mark, Patrick B
- Subjects
Renal and urogenital ,Chronic Kidney Disease Prognosis Consortium ,Clinical Sciences ,Urology & Nephrology - Abstract
The Chronic Kidney Disease (CKD) Prognosis Consortium is a collaborative author of the above-mentioned article. The CKD Prognosis Consortium investigators/collaborators are as follows: • African American Study of Kidney Disease and Hypertension (AASK): Brad Astor, Lawrence J. Appel; Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT): Adeera Levin, Mila Tang, Ognjenka Djurdjev; Cleveland Clinic CKD Registry Study (CCF): Sankar D. Navaneethan, Stacey E. Jolly, Jesse D. Schold, Joseph V. Nally Jr.; Chronic Renal Impairment in Birmingham (CRIB): David C. Wheeler, Jonathan Emberson, John Townend, Martin Landray; Chronic Renal Insufficiency Cohort Study (CRIC): Harold I. Feldman, Chi-yuan Hsu, James P. Lash, Lawrence J. Appel; Chronic Renal Insufficiency Standards Implementation Study (CRISIS): Philip A. Kalra, James P. Ritchie, Raman Maharajan, Rachel J. Middleton, Donal J. O'Donoghue; German Chronic Kidney Disease Study (GCKD): Kai-Uwe Eckardt, Markus P. Schneider, Anna Köttgen, Florian Kronenberg, Barbara Bärthlein; Geisinger Health System: Alex R. Chang, Jamie A. Green, H. Lester Kirchner, Kevin Ho; Grampian Laboratory Outcomes, Morbidity and Mortality Studies – 2 (GLOMMS2): Angharad Marks, Corri Black, Gordon J. Prescott, Nick Fluck; Gonryo Study: Masaaki Nakayama, Mariko Miyazaki, Tae Yamamoto, Gen Yamada; Hong Kong CKD Studies: Angela Yee-Moon Wang, Sharon Cheung, Sharon Wong, Jessie Chu, Henry Wu; Ontario Institute for Clinical Evaluative Sciences, Provincial Kidney, Dialysis and Transplantation program (ICES KDT): Amit X. Garg, Eric McArthur, Danielle M. Nash; Maccabi Health System: Varda Shalev, Gabriel Chodick; Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN): Peter J. Blankestijn, Jack F.M. Wetzels, Arjan D. van Zuilen, Jan A. van den Brand; Modification of Diet in Renal Disease Study (MDRD): Andrew S. Levey, Lesley A. Inker, Mark J. Sarnak, Hocine Tighiouart; Nanjing CKD Network Cohort Study (Nanjing CKD): Haitao Zhang; NephroTest Study (NephroTest): Benedicte Stengel, Marie Metzger, Martin Flamant, Pascal Houillier, Jean-Philippe Haymann; National Renal Healthcare Program – Uruguay (NRHP-URU): Pablo G. Rios, Nelson Mazzuchi, Liliana Gadola, Verónica Lamadrid, Laura Sola; New Zealand Diabetes Cohort Study (NZDCS): John F. Collins, C. Raina Elley, Timothy Kenealy; Parcours de Soins des Personnes Agées (PSPA): Olivier Moranne, Cecile Couchoud, Cecile Vigneau; Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease (PSP CKD): Nigel J. Brunskill, Rupert W. Major, David Shepherd, James F. Medcalf; Racial and Cardiovascular Risk Anomalies in CKD Cohort (RCAV): Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Miklos Z. Molnar, Keiichi Sumida, Praveen K. Potukuchi; Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL): Hiddo J.L. Heerspink, Dick de Zeeuw, Barry Brenner; Stockholm CREAtinine Measurements Cohort (SCREAM): Juan Jesus Carrero, Alessandro Gasparini, Abdul Rashid Qureshi, Carl-Gustaf Elinder; Second Manifestations of ARTerial Disease Study (SMART): Frank L.J. Visseren, Yolanda van der Graaf; Swedish Renal Registry CKD Cohort (SRR CKD): Marie Evans, Maria Stendahl, Staffan Schön, Mårten Segelmark, Karl-Göran Prütz; Sunnybrook Cohort: David M. Naimark, Navdeep Tangri; West of Scotland CKD Study: Patrick B. Mark, Jamie P. Traynor, Colin C. Geddes, Peter C. Thomson.• CKD Prognosis Consortium Steering Committee: Alex R. Chang, Josef Coresh (Chair), Ron T. Gansevoort, Morgan E. Grams, Anna Köttgen, Andrew S. Levey, Kunihiro Matsushita, Mark Woodward, Luxia Zhang.• CKD Prognosis Consortium Data Coordinating Center: Shoshana H. Ballew (Assistant Project Director), Jingsha Chen (Programmer), Josef Coresh (Principal Investigator), Morgan E. Grams (Director of Nephrology Initiatives), Lucia Kwak (Programmer), Kunihiro Matsushita (Director), Yingying Sang (Lead Programmer), Aditya Surapaneni (Programmer), Mark Woodward (Senior Statistician).• Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on Prognosis and Optimal Management of Patients with Advanced CKD: Kai-Uwe Eckardt (Conference Co-Chair), Brenda R. Hemmelgarn (Conference Co-Chair), David C. Wheeler (KDIGO Co-Chair), Wolfgang C. Winkelmayer (KDIGO Co-Chair), John Davis (CEO), Danielle Green (Managing Director), Michael Cheung (Chief Scientific Officer), Tanya Green (Communications Director), Melissa McMahan (Programs Director).
- Published
- 2018
5. Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637
- Author
-
Astor, Brad, Appel, Lawrence J, Levin, Adeera, Djurdjev, Ognjenka, Tang, Mila, Navaneethan, Sankar D, Jolly, Stacey E, Schold, Jesse D, Nally, Joseph V, Wheeler, David C, Emberson, Jonathan, Townend, John, Landray, Martin, Feldman, Harold I, Hsu, Chi-yuan, Lash, James P, Kalra, Philip A, Ritchie, James P, Maharajan, Raman, Alderson, Helen, Lane, Beverly, Eckardt, Kai-Uwe, Schneider, Markus P, Köttgen, Anna, Kronenberg, Florian, Bärthlein, Barbara, Chang, Alex R, Green, Jamie A, Kirchner, H Lester, Ho, Kevin, Marks, Angharad, Black, Corri, Prescott, Gordon J, Fluck, Nick, Nakayama, Masaaki, Miyazaki, Mariko, Yamamoto, Tae, Yamada, Wang, Angela Yee-Moon, Cheung, Sharon, Wong, Sharon, Chu, Jessie, Wu, Henry, Shalev, Varda, Chodick, Gabriel, Blankestijn, Peter J, Wetzels, Jack FM, van Zuilen, Arjan D, van den Brand, Jan A, Levey, Andrew S, Inker, Lesley A, Sarnak, Mark J, Tighiouart, Hocine, Zhang, Haitao, Stengel, Benedicte, Rios, Pablo G, Mazzuchi, Nelson, Gadola, Liliana, Lamadrid, Verónica, Sola, Laura, Collins, John F, Elley, C Raina, Kenealy, Timothy, Moranne, Olivier, Couchoud, Cecile, Vigneau, Cecile, Brunskill, Nigel J, Major, Rupert W, Shepherd, David, Medcalf, James F, Kovesdy, Csaba P, Kalantar-Zadeh, Kamyar, Molnar, Miklos Z, Sumida, Keiichi, Potukuchi, Praveen K, Heerspink, Hiddo JL, de Zeeuw, Dick, Brenner, Barry, Carrero, Juan Jesus, Barany, Peter, Qureshi, Abdul Rashid, Elinder, Carl-Gustaf, Visseren, Frank LJ, van der Graaf, Yolanda, Evans, Marie, Stendahl, Maria, Schön, Staffan, Segelmark, Mårten, Prütz, Karl-Göran, Naimark, David M, Tangri, Navdeep, Mark, Patrick B, Traynor, Jamie P, Geddes, Colin C, Thomson, Peter C, and Coresh, Josef
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Renal and urogenital ,Good Health and Well Being ,Chronic Kidney Disease Prognosis Consortium ,Biomedical and clinical sciences ,Health sciences - Abstract
[This corrects the article DOI: 10.1016/j.ekir.2018.01.002.].
- Published
- 2018
6. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
- Author
-
Matsushita, Kunihiro, Ballew, Shoshana H, Coresh, Josef, Arima, Hisatomi, Ärnlöv, Johan, Cirillo, Massimo, Ebert, Natalie, Hiramoto, Jade S, Kimm, Heejin, Shlipak, Michael G, Visseren, Frank LJ, Gansevoort, Ron T, Kovesdy, Csaba P, Shalev, Varda, Woodward, Mark, Kronenberg, Florian, Chalmers, John, Perkovic, Vlado, Grams, Morgan E, Sang, Yingying, Schaeffner, Elke, Martus, Peter, Levin, Adeera, Djurdjev, Ognjenka, Tang, Mila, Heine, Gunnar, Seiler, Sarah, Zawada, Adam, Emrich, Insa, Sarnak, Mark, Katz, Ronit, Brenner, Hermann, Schöttker, Ben, Rothenbacher, Dietrich, Saum, Kai-Uwe, Köttgen, Anna, Schneider, Markus, Eckardt, Kai-Uwe, Green, Jamie, Kirchner, H Lester, Chang, Alex R, Black, Corri, Marks, Angharad, Prescott, Gordon, Clark, Laura, Fluck, Nick, Jee, Sun Ha, Mok, Yejin, Chodick, Gabriel, Wetzels, Jack FM, Blankestijn, Peter J, van Zuilen, Arjan D, Bots, M, Peralta, Carmen, Hiromoto, Jade, Bottinger, Erwin, Nadkarni, Girish N, Ellis, Stephen B, Nadukuru, Rajiv, Kenealy, Timothy, Elley, C Raina, Collins, John F, Drury, Paul L, Bakker, Stephan JL, Heerspink, Hiddo J Lambers, Jassal, Simerjot K, Bergstrom, Jaclyn, Ix, Joachim H, Barrett-Connor, Elizabeth, Kalantar-Zadeh, Kamyar, Carrero, Juan J, Gasparini, Alessandro, Qureshi, Abdul Rashid, Barany, Peter, Algra, Ale, van der Graaf, Yolanda, Evans, Marie, Segelmark, Mårten, Stendahl, Maria, Schön, Staffan, Tangri, Navdeep, Sud, Maneesh, Naimark, David, Lannfelt, Lars, Larsson, Anders, Hallan, Stein, Levey, Andrew S, Chen, Jingsha, and Kwak, Lucia
- Subjects
Clinical Research ,Kidney Disease ,Prevention ,Renal and urogenital ,Good Health and Well Being ,Adult ,Aged ,Albuminuria ,Creatinine ,Databases ,Factual ,Female ,Glomerular Filtration Rate ,Humans ,Incidence ,Male ,Middle Aged ,Peripheral Arterial Disease ,Renal Insufficiency ,Chronic ,Risk Factors ,Chronic Kidney Disease Prognosis Consortium ,Medical Biochemistry and Metabolomics ,Clinical Sciences ,Public Health and Health Services - Abstract
BackgroundSome evidence suggests that chronic kidney disease is a risk factor for lower-extremity peripheral artery disease. We aimed to quantify the independent and joint associations of two measures of chronic kidney disease (estimated glomerular filtration rate [eGFR] and albuminuria) with the incidence of peripheral artery disease.MethodsIn this collaborative meta-analysis of international cohorts included in the Chronic Kidney Disease Prognosis Consortium (baseline measurements obtained between 1972 and 2014) with baseline measurements of eGFR and albuminuria, at least 1000 participants (this criterion not applied to cohorts exclusively enrolling patients with chronic kidney disease), and at least 50 peripheral artery disease events, we analysed adult participants without peripheral artery disease at baseline at the individual patient level with Cox proportional hazards models to quantify associations of creatinine-based eGFR, urine albumin-to-creatinine ratio (ACR), and dipstick proteinuria with the incidence of peripheral artery disease (including hospitalisation with a diagnosis of peripheral artery disease, intermittent claudication, leg revascularisation, and leg amputation). We assessed discrimination improvement through c-statistics.FindingsWe analysed 817 084 individuals without a history of peripheral artery disease at baseline from 21 cohorts. 18 261 cases of peripheral artery disease were recorded during follow-up across cohorts (median follow-up was 7·4 years [IQR 5·7-8·9], range 2·0-15·8 years across cohorts). Both chronic kidney disease measures were independently associated with the incidence of peripheral artery disease. Compared with an eGFR of 95 mL/min per 1·73 m2, adjusted hazard ratios (HRs) for incident study-specific peripheral artery disease was 1·22 (95% CI 1·14-1·30) at an eGFR of 45 mL/min per 1·73 m2 and 2·06 (1·70-2·48) at an eGFR of 15 mL/min per 1·73 m2. Compared with an ACR of 5 mg/g, the adjusted HR for incident study-specific peripheral artery disease was 1·50 (1·41-1·59) at an ACR of 30 mg/g and 2·28 (2·12-2·44) at an ACR of 300 mg/g. The adjusted HR at an ACR of 300 mg/g versus 5 mg/g was 3·68 (95% CI 3·00-4·52) for leg amputation. eGFR and albuminuria contributed multiplicatively (eg, adjusted HR 5·76 [4·90-6·77] for incident peripheral artery disease and 10·61 [5·70-19·77] for amputation in eGFR
- Published
- 2017
7. Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis
- Author
-
Tangri, Navdeep, Grams, Morgan E, Levey, Andrew S, Coresh, Josef, Appel, Lawrence J, Astor, Brad C, Chodick, Gabriel, Collins, Allan J, Djurdjev, Ognjenka, Elley, C Raina, Evans, Marie, Garg, Amit X, Hallan, Stein I, Inker, Lesley A, Ito, Sadayoshi, Jee, Sun Ha, Kovesdy, Csaba P, Kronenberg, Florian, Heerspink, Hiddo JL, Marks, Angharad, Nadkarni, Girish N, Navaneethan, Sankar D, Nelson, Robert G, Titze, Stephanie, Sarnak, Mark J, Stengel, Benedicte, Woodward, Mark, and Iseki, Kunitoshi
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Clinical Research ,Prevention ,Kidney Disease ,Renal and urogenital ,Cohort Studies ,Disease Progression ,Humans ,Prognosis ,Proportional Hazards Models ,Renal Insufficiency ,Renal Insufficiency ,Chronic ,Risk Assessment ,CKD Prognosis Consortium ,Medical and Health Sciences ,General & Internal Medicine ,Biomedical and clinical sciences ,Health sciences - Abstract
ImportanceIdentifying patients at risk of chronic kidney disease (CKD) progression may facilitate more optimal nephrology care. Kidney failure risk equations, including such factors as age, sex, estimated glomerular filtration rate, and calcium and phosphate concentrations, were previously developed and validated in 2 Canadian cohorts. Validation in other regions and in CKD populations not under the care of a nephrologist is needed.ObjectiveTo evaluate the accuracy of the risk equations across different geographic regions and patient populations through individual participant data meta-analysis.Data sourcesThirty-one cohorts, including 721,357 participants with CKD stages 3 to 5 in more than 30 countries spanning 4 continents, were studied. These cohorts collected data from 1982 through 2014.Study selectionCohorts participating in the CKD Prognosis Consortium with data on end-stage renal disease.Data extraction and synthesisData were obtained and statistical analyses were performed between July 2012 and June 2015. Using the risk factors from the original risk equations, cohort-specific hazard ratios were estimated and combined using random-effects meta-analysis to form new pooled kidney failure risk equations. Original and pooled kidney failure risk equation performance was compared, and the need for regional calibration factors was assessed.Main outcomes and measuresKidney failure (treatment by dialysis or kidney transplant).ResultsDuring a median follow-up of 4 years of 721,357 participants with CKD, 23,829 cases kidney failure were observed. The original risk equations achieved excellent discrimination (ability to differentiate those who developed kidney failure from those who did not) across all cohorts (overall C statistic, 0.90; 95% CI, 0.89-0.92 at 2 years; C statistic at 5 years, 0.88; 95% CI, 0.86-0.90); discrimination in subgroups by age, race, and diabetes status was similar. There was no improvement with the pooled equations. Calibration (the difference between observed and predicted risk) was adequate in North American cohorts, but the original risk equations overestimated risk in some non-North American cohorts. Addition of a calibration factor that lowered the baseline risk by 32.9% at 2 years and 16.5% at 5 years improved the calibration in 12 of 15 and 10 of 13 non-North American cohorts at 2 and 5 years, respectively (P = .04 and P = .02).Conclusions and relevanceKidney failure risk equations developed in a Canadian population showed high discrimination and adequate calibration when validated in 31 multinational cohorts. However, in some regions the addition of a calibration factor may be necessary.
- Published
- 2016
8. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
- Author
-
James, Matthew T, Grams, Morgan E, Woodward, Mark, Elley, C Raina, Green, Jamie A, Wheeler, David C, de Jong, Paul, Gansevoort, Ron T, Levey, Andrew S, Warnock, David G, Sarnak, Mark J, Tonelli, Marcello, Hemmelgarn, Brenda R, Turin, Tanvir Chowdhury, Coresh, Josef, Matsushita, Kunihiro, Grams, Morgan, Sang, Yingying, Shlipak, Michael, Katz, Ronit, Emberson, Jonathan, Landray, Martin J, Townend, Jonathan N, Green, Jamie, Kirchner, H Les, Perkins, Robert, Chang, Alex R, Romundstad, Solfrid, Aasarød, Knut, Øien, Cecilia M, Hallan, Stein, Smith, David H, Thorp, Micah L, Johnson, Eric S, Chodick, Gabriel, Herzel, Esma, Katz, Rachel, Shalev, Varda, Bakker, Stephan JL, Heerspink, Hiddo J Lambers, van der Harst, Pim, Jee, Sun Ha, Kimm, Heejin, Mok, Yejin, Tangri, Navdeep, Naimark, David, Ärnlöv, Johan, Larsson, Anders, Lannfelt, Lars, Kovesdy, Csaba P, Kalantar-Zadeh, Kamyar, de Jong, Paul E, Iseki, Kunitoshi, Stengel, Benedicte, Warnock, David, and Ballew, Shoshana H
- Subjects
Nutrition ,Kidney Disease ,Clinical Research ,Diabetes ,4.2 Evaluation of markers and technologies ,Detection ,screening and diagnosis ,Metabolic and endocrine ,Renal and urogenital ,Acute Kidney Injury ,Adult ,Aged ,Comorbidity ,Diabetes Mellitus ,Disease Progression ,Female ,Glomerular Filtration Rate ,Humans ,Hypertension ,Incidence ,Kidney Failure ,Chronic ,Male ,Middle Aged ,Prognosis ,Renal Insufficiency ,Chronic ,Estimated glomerular filtration rate ,renal function ,albuminuria ,albumin-creatine ratio ,diabetes ,hypertension ,acute kidney injury ,acute renal failure ,Chronic Kidney Disease Prognosis Consortium ,meta-analysis ,CKD Prognosis Consortium ,Clinical Sciences ,Public Health and Health Services ,Urology & Nephrology - Abstract
BackgroundDiabetes mellitus and hypertension are risk factors for acute kidney injury (AKI). Whether estimated glomerular filtration rate (eGFR) and urine albumin-creatinine ratio (ACR) remain risk factors for AKI in the presence and absence of these conditions is uncertain.Study designMeta-analysis of cohort studies.Setting & population8 general-population (1,285,045 participants) and 5 chronic kidney disease (CKD; 79,519 participants) cohorts.Selection criteria for studiesCohorts participating in the CKD Prognosis Consortium.PredictorsDiabetes and hypertension status, eGFR by the 2009 CKD Epidemiology Collaboration creatinine equation, urine ACR, and interactions.OutcomeHospitalization with AKI, using Cox proportional hazards models to estimate HRs of AKI and random-effects meta-analysis to pool results.ResultsDuring a mean follow-up of 4 years, there were 16,480 episodes of AKI in the general-population and 2,087 episodes in the CKD cohorts. Low eGFRs and high ACRs were associated with higher risks of AKI in individuals with or without diabetes and with or without hypertension. When compared to a common reference of eGFR of 80mL/min/1.73m(2) in nondiabetic patients, HRs for AKI were generally higher in diabetic patients at any level of eGFR. The same was true for diabetic patients at all levels of ACR compared with nondiabetic patients. The risk gradient for AKI with lower eGFRs was greater in those without diabetes than with diabetes, but similar with higher ACRs in those without versus with diabetes. Those with hypertension had a higher risk of AKI at eGFRs>60mL/min/1.73m(2) than those without hypertension. However, risk gradients for AKI with both lower eGFRs and higher ACRs were greater for those without than with hypertension.LimitationsAKI identified by diagnostic code.ConclusionsLower eGFRs and higher ACRs are associated with higher risks of AKI among individuals with or without either diabetes or hypertension.
- Published
- 2015
9. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data
- Author
-
Chalmers, John, Arima, Hisatomi, Perkovic, Vlado, Grams, Morgan E., Sang, Yingying, Schaeffner, Elke, Martus, Peter, Levin, Adeera, Djurdjev, Ognjenka, Tang, Mila, Heine, Gunnar, Seiler, Sarah, Zawada, Adam, Emrich, Insa, Sarnak, Mark, Katz, Ronit, Brenner, Hermann, Schöttker, Ben, Rothenbacher, Dietrich, Saum, Kai-Uwe, Köttgen, Anna, Schneider, Markus, Eckardt, Kai-Uwe, Green, Jamie, Kirchner, H Lester, Chang, Alex R, Black, Corri, Marks, Angharad, Prescott, Gordon, Clark, Laura, Fluck, Nick, Jee, Sun Ha, Mok, Yejin, Chodick, Gabriel, Shalev, Varda, Wetzels, Jack F.M., Blankestijn, Peter J, van Zuilen, Arjan D, Bots, M, Peralta, Carmen, Hiromoto, Jade, Bottinger, Erwin, Nadkarni, Girish N, Ellis, Stephen B, Nadukuru, Rajiv, Kenealy, Timothy, Elley, C Raina, Collins, John F, Drury, Paul L, Bakker, Stephan JL, Heerspink, Hiddo J Lambers, Jassal, Simerjot K, Bergstrom, Jaclyn, Ix, Joachim H, Barrett-Connor, Elizabeth, Kalantar-Zadeh, Kamyar, Carrero, Juan J, Gasparini, Alessandro, Qureshi, Abdul Rashid, Barany, Peter, Algra, Ale, van der Graaf, Yolanda, Evans, Marie, Segelmark, Mårten, Stendahl, Maria, Schön, Staffan, Tangri, Navdeep, Sud, Maneesh, Naimark, David, Lannfelt, Lars, Larsson, Anders, Hallan, Stein, Levey, Andrew S, Chen, Jingsha, Kwak, Lucia, Matsushita, Kunihiro, Ballew, Shoshana H, Coresh, Josef, Ärnlöv, Johan, Cirillo, Massimo, Ebert, Natalie, Hiramoto, Jade S, Kimm, Heejin, Shlipak, Michael G, Visseren, Frank L J, Gansevoort, Ron T, Kovesdy, Csaba P, Woodward, Mark, and Kronenberg, Florian
- Published
- 2017
- Full Text
- View/download PDF
10. Exploring the maternal and infant continuum – ethnic disparities in infant hospital admissions for respiratory disease
- Author
-
Lawton, Beverley, Stanley, James, Filoche, Sara, Garrett, Sue, Rose, Sally B., Robson, Bridget, and Elley, C. Raina
- Published
- 2016
- Full Text
- View/download PDF
11. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
- Author
-
Tonelli, Marcello, Hemmelgarn, Brenda R., James, Matthew T., Turin, Tanvir Chowdhury, Coresh, Josef, Matsushita, Kunihiro, Grams, Morgan, Sang, Yingying, Shlipak, Michael, Sarnak, Mark J., Katz, Ronit, Wheeler, David C., Emberson, Jonathan, Landray, Martin J., Townend, Jonathan N., Green, Jamie, Kirchner, H. Les, Perkins, Robert, Chang, Alex R., Romundstad, Solfrid, Aasarød, Knut, Øien, Cecilia M., Hallan, Stein, Smith, David H., Thorp, Micah L., Johnson, Eric S., Chodick, Gabriel, Herzel, Esma, Katz, Rachel, Shalev, Varda, Gansevoort, Ron T., Bakker, Stephan J.L., Lambers Heerspink, Hiddo J., van der Harst, Pim, Jee, Sun Ha, Kimm, Heejin, Mok, Yejin, Tangri, Navdeep, Naimark, David, Ärnlöv, Johan, Larsson, Anders, Lannfelt, Lars, Kovesdy, Csaba P., Kalantar-Zadeh, Kamyar, de Jong, Paul E., Iseki, Kunitoshi, Levey, Andrew S., Stengel, Benedicte, Warnock, David, Woodward, Mark, Ballew, Shoshana H., Grams, Morgan E., Elley, C. Raina, Green, Jamie A., de Jong, Paul, and Warnock, David G.
- Published
- 2015
- Full Text
- View/download PDF
12. Preventing Diabetes in Primary Care: A Feasibility Cluster Randomized Trial
- Author
-
Dawes, Diana, Ashe, Maureen, Campbell, Kristin, Cave, Douglas, Elley, C. Raina, Kaczorowski, Janusz, Sohal, Parmjit, Ur, Ehud, and Dawes, Martin
- Published
- 2015
- Full Text
- View/download PDF
13. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease : randomised controlled trial in primary care
- Author
-
Selak, Vanessa, Elley, C Raina, Bullen, Chris, Crengle, Sue, Wadham, Angela, Rafter, Natasha, Parag, Varsha, Harwood, Matire, Doughty, Robert N, Arroll, Bruce, Milne, Richard J, Bramley, Dale, Bryant, Linda, Jackson, Rod, and Rodgers, Anthony
- Published
- 2014
14. Abstract 15450: International Validation of the TIMI Risk Score for Secondary Prevention in Post-MI Patients: A Collaborative Analysis of the Chronic Kidney Disease Prognosis Consortium and the Risk Validation Scientific Committee
- Author
-
Mok, Yejin, Ballew, Shoshana, Bhatt, Deepak L, Boden, William E, Bonaca, Marc P, Carrero, Juan-Jesus, Coresh, Josef, Elley, C. Raina, Fowkes, Gerry R, Jee, Sun Ha, Kovesdy, Csaba, Mahaffey, Kenneth W, Nadkarni, Girish, Sang, Yingying, and Matsushita, Kunihiro
- Published
- 2017
15. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: The SPACE Collaboration
- Author
-
Webster, Ruth, Patel, Anushka, Billot, Laurent, Cass, Alan, Burch, Carol, Neal, Bruce, Usherwood, Tim, Thom, Simon, Poulter, Neil, Stanton, Alice, Bots, Michiel L., Grobbee, Diederick E., Prabhakaran, Dorairaj, Reddy, K. Srinath, Field, Jane, Bullen, Chris, Elley, C. Raina, Selak, Vanessa, Rafter, Natasha, Wadham, Angela, Berwanger, Otavio, and Rodgers, Anthony
- Published
- 2013
- Full Text
- View/download PDF
16. The assessment and management of insomnia in primary care
- Author
-
Falloon, Karen, Arroll, Bruce, Elley, C Raina, and Fernando, Antonio
- Published
- 2011
17. Exercise on Prescription for Women Aged 40-74 Recruited through Primary Care: Two Year Randomised Controlled Trial
- Author
-
Lawton, Beverley A., Rose, Sally B., Elley, C. Raina, Dowell, Anthony C., Fenton, Anna, and Moyes, Simon A.
- Published
- 2009
- Full Text
- View/download PDF
18. Uncertainties Page: Should We Prescribe Diuretics for Patients with Prediabetes and Hypertension?
- Author
-
Arroll, Bruce, Kenealy, Timothy, and Elley, C. Raina
- Published
- 2008
- Full Text
- View/download PDF
19. Improving adherence using combination therapy (IMPACT): Design and protocol of a randomised controlled trial in primary care
- Author
-
Selak, Vanessa, Elley, C. Raina, Crengle, Sue, Harwood, Matire, Doughty, Rob, Arroll, Bruce, Bryant, Linda, Rafter, Natasha, Hoorn, Stephen Vander, Wadham, Angela, Wells, Sue, Milne, Richard, Jackson, Rod, Bramley, Dale, and Rodgers, Anthony
- Published
- 2011
- Full Text
- View/download PDF
20. Normative values of hip strength in adult male association football players assessed by handheld dynamometry
- Author
-
Hanna, Chris M., Fulcher, Mark L., Elley, C. Raina, and Moyes, Simon A.
- Published
- 2010
- Full Text
- View/download PDF
21. Effectiveness Of Counselling Patients On Physical Activity In General Practice: Cluster Randomised Controlled Trial
- Author
-
Elley, C. Raina, Kerse, Ngaire, Arroll, Bruce, and Robinson, Elizabeth
- Published
- 2003
22. Trends in the management of risk of diabetes complications in different ethnic groups in New Zealand primary care
- Author
-
Agban, Hosnah, Elley, C. Raina, Kenealy, Tim, and Robinson, Elizabeth
- Published
- 2008
- Full Text
- View/download PDF
23. Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand
- Author
-
Elley, C. Raina, Kenealy, Tim, Robinson, Elizabeth, Bramley, Dale, Selak, Vanessa, Drury, Paul L., Kerse, Ngaire, Pearson, Janet, Lay-Yee, Roy, and Arroll, Bruce
- Published
- 2008
- Full Text
- View/download PDF
24. Poor uptake of self-sample collection kits for Chlamydia testing outside primary care
- Author
-
Rose, Sally B., Lawton, Beverley A., Bromhead, Collette, MacDonald, E. Jane, and Elley, C. Raina
- Subjects
Self-examination, Medical -- Methods ,Medically underserved areas -- Medical examination ,Chlamydia -- Diagnosis ,Company distribution practices ,Health - Abstract
Objectives: New strategies are needed to reach at-risk populations for Chlamydia screening. Method: Self-sample collection kits containing instructions and all items required for testing were developed and piloted in a three-month trial in primary care. Practice staff offered kits to young people receiving opportunistic Chlamydia screening to pass on to their 'social contacts.' Results: The 'pass it on' approach failed to reach adequate numbers of youth for testing: of 67 kits distributed, three specimens were sent to the laboratory (4.5%). Conclusions: The method of kit distribution trialled here was not successful in reaching at-risk youth for testing outside the primary care setting. Implications: Use of self-sample collection for chlamydia testing outside healthcare settings is likely to be important for increased access to testing. The importance of chlamydia testing needs to be widely promoted and methods for kit distribution to reach at-risk youth identified. Key words: chlamydia, screening, self-collection, at-risk youth. Aust NZ J Public Health. 2010; 34:517-20 doi: 10.1111/j.1753-6405.2010.00600.x
- Published
- 2010
25. Standardised criteria improve accuracy of ECG interpretation in competitive athletes: a randomised controlled trial
- Author
-
Exeter, Daniel J, Elley, C Raina, Fulcher, Mark L, Lee, Arier C, Drezner, Jonathan A, and Asif, Irfan M
- Published
- 2014
- Full Text
- View/download PDF
26. A Theory-Based Video Messaging Mobile Phone Intervention for Smoking Cessation: Randomized Controlled Trial
- Author
-
Whittaker, Robyn, Dorey, Enid, Bramley, Dale, Bullen, Chris, Denny, Simon, Elley, C Raina, Maddison, Ralph, McRobbie, Hayden, Parag, Varsha, Rodgers, Anthony, and Salmon, Penny
- Subjects
Computer applications to medicine. Medical informatics ,R858-859.7 ,Public aspects of medicine ,RA1-1270 - Abstract
Background Advances in technology allowed the development of a novel smoking cessation program delivered by video messages sent to mobile phones. This social cognitive theory-based intervention (called “STUB IT”) used observational learning via short video diary messages from role models going through the quitting process to teach behavioral change techniques. Objective The objective of our study was to assess the effectiveness of a multimedia mobile phone intervention for smoking cessation. Methods A randomized controlled trial was conducted with 6-month follow-up. Participants had to be 16 years of age or over, be current daily smokers, be ready to quit, and have a video message-capable phone. Recruitment targeted younger adults predominantly through radio and online advertising. Registration and data collection were completed online, prompted by text messages. The intervention group received an automated package of video and text messages over 6 months that was tailored to self-selected quit date, role model, and timing of messages. Extra messages were available on demand to beat cravings and address lapses. The control group also set a quit date and received a general health video message sent to their phone every 2 weeks. ResultsThe target sample size was not achieved due to difficulty recruiting young adult quitters. Of the 226 randomized participants, 47% (107/226) were female and 24% (54/226) were Maori (indigenous population of New Zealand). Their mean age was 27 years (SD 8.7), and there was a high level of nicotine addiction. Continuous abstinence at 6 months was 26.4% (29/110) in the intervention group and 27.6% (32/116) in the control group (P = .8). Feedback from participants indicated that the support provided by the video role models was important and appreciated. Conclusions This study was not able to demonstrate a statistically significant effect of the complex video messaging mobile phone intervention compared with simple general health video messages via mobile phone. However, there was sufficient positive feedback about the ease of use of this novel intervention, and the support obtained by observing the role model video messages, to warrant further investigation. Trial registration Australian New Zealand Clinical Trials Registry Number: ACTRN12606000476538; http://www.anzctr.org.au/trial_view.aspx?ID=81688 (Archived by WebCite at http://www.webcitation.org/5umMU4sZi)
- Published
- 2011
- Full Text
- View/download PDF
27. Cost utility analysis of physical activity counselling in general practice
- Author
-
Dalziel, Kim, Segal, Leonie, and Elley, C. Raina
- Subjects
Physical fitness -- Analysis ,Family medicine -- Analysis ,Cost benefit analysis ,Cost benefit analysis ,Health - Abstract
Objective: To evaluate the economic performance of the 'Green Prescription' physical activity counselling program in general practice. Methods: Cost utility analysis using a Markov model was used to estimate the cost utility of the Green Prescription program over full life expectancy. Program effectiveness was based on published trial data (878 inactive patients presenting to NZ general practice). Costs were based on detailed costing information and were discounted at 5% per anum. The main outcome measure is cost per quality adjusted life year (QALY) gained. Extensive one-way sensitivity analyses were performed along with probabilistic (stochastic) analysis. Results: Incremental, modelled cost utility of the Green Prescription program compared with 'usual care' was $NZ2,053 per QALY gained over full life expectancy (range $NZ827 to $NZ37,516 per QALY). Based on the probabilistic sensitivity analysis, 90% of ICERs fell below $NZ7,500 per QALY. Conclusions: Based on a plausible and conservative set of assumptions, if decision makers are willing to pay at least $NZ2,000 per QALY gained the Green Prescription program is likely to represent better value for money than 'usual care'. Implications: The Green Prescription program performs well, representing a good buy relative to other published cost effectiveness estimates. Policy makers should consider encouraging general practitioners to prescribe physical activity advice in the primary care setting, in association with support from exercise specialists.
- Published
- 2006
28. Intraclass correlation coefficients from three cluster randomised controlled trials in primary and residential health care
- Author
-
Elley, C. Raina, Kerse, Ngaire, Chondros, Patty, and Robinson, Elizabeth
- Subjects
Medical care -- Surveys ,Medical care -- Demographic aspects ,Medical care -- Quality management ,Medical care -- Australia ,Medical care -- New Zealand ,Home care -- Surveys ,Home care -- Quality management ,Home care -- Demographic aspects ,Health - Abstract
Objective: This paper provides intraclass correlation coefficients (ICCs) for estimation of sample size inflation required in future cluster randomised trials in primary or residential care. Methods: Three cluster randomised trials were conducted among middle-aged and older adults in primary care and residential care in Australia and New Zealand between 1995 and 2002. Baseline means or proportions, mean change, and ICCs with their standard errors and 95% confidence intervals are reported for outcome variables used in the three studies. The ICCs were estimated from a one-way random effects model using the analysis of variance method. Results: ICCs for quality of life and psychological variables in the primary care studies were low (below 0.018). ICCs for clinical and physical activity variables ranged from 0 to 0.08. ICCs for health and functional status in residential care for the elderly were high, ranging from 0.025 to 0.514. Conclusions: The magnitude of the intraclass correlation varies with the venue of the trial, the outcome variables used, and the expected effect of the intervention. However, the intraclass correlations provided will be useful for more appropriate planning of residential and primary care-based trials in the future.
- Published
- 2005
29. Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes
- Author
-
Elley, C. Raina, Robinson, Tom, Moyes, Simon A., Kenealy, Tim, Collins, John, Robinson, Elizabeth, Orr-Walker, Brandon, and Drury, Paul L.
- Published
- 2013
- Full Text
- View/download PDF
30. The eCHAT Program to Facilitate Healthy Changes in New Zealand Primary Care
- Author
-
Goodyear-Smith, Felicity, Warren, James, and Elley, C. Raina
- Published
- 2013
31. Cost-effectiveness of exercise on prescription with telephone support among women in general practice over 2 years
- Author
-
Elley, C Raina, Garrett, Sue, Rose, Sally B, OʼDea, Des, Lawton, Beverley A, Moyes, Simon A, and Dowell, Anthony C
- Published
- 2011
- Full Text
- View/download PDF
32. Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes: The New Zealand Diabetes Cohort Study
- Author
-
Elley, C. Raina, Robinson, Elizabeth, Kenealy, Tim, Bramley, Dale, and Drury, Paul L.
- Published
- 2010
- Full Text
- View/download PDF
33. Quality indicators to measure blood pressure management over a time interval
- Author
-
Mabotuwana, Thusitha, Warren, Jim, Elley, C Raina, Kennelly, John, Paton, Chris, Wai, Kuinileti Chang, and Wells, Stewart
- Published
- 2010
34. Use of interval based quality indicators in blood pressure management to enhance quality of pay for performance incentives: comparison to two indicators from the Quality and Outcomes Framework
- Author
-
Mabotuwana, Thusitha, Warren, Jim, Elley, C Raina, Kennelly, John, Paton, Chris, Warren, Debra, Wai, Kuinileti Chang, and Wells, Stewart
- Published
- 2010
35. Intensive primary care treatment reduced cardiovascular risk factors in screen-detected type 2 diabetes
- Author
-
Elley, C Raina and Kenealy, Tim
- Published
- 2009
36. Should we prescribe diuretics for patients with prediabetes and hypertension?
- Author
-
Arroll, Bruce, Kenealy, Timothy, and Elley, C Raina
- Published
- 2008
37. Lifestyle interventions reduced the long-term risk of diabetes in adults with impaired glucose tolerance
- Author
-
Elley, C Raina and Kenealy, Tim
- Published
- 2008
38. Effectiveness of a Falls-and-Fracture Nurse Coordinator to Reduce Falls: A Randomized, Controlled Trial of At-Risk Older Adults: (See editorial comments by Dr. Mary Tinetti on pp 1563–1565)
- Author
-
Elley, C. Raina, Robertson, M. Clare, Garrett, Sue, Kerse, Ngaire M., McKinlay, Eileen, Lawton, Beverley, Moriarty, Helen, Moyes, Simon A., and Campbell, A. John
- Published
- 2008
39. Review: regular brisk walking improves cardiovascular risk factors in healthy sedentary adults
- Author
-
Elley, C Raina and Arroll, Bruce
- Published
- 2007
40. Is Physical Activity Counseling Effective for Older People? A Cluster Randomized, Controlled Trial in Primary Care
- Author
-
Kerse, Ngaire, Elley, C. Raina, Robinson, Elizabeth, and Arroll, Bruce
- Published
- 2005
41. Development of Risk Prediction Equations for Incident Chronic Kidney Disease
- Author
-
Nelson, Robert G., Grams, Morgan E., Ballew, Shoshana H., Sang, Yingying, Azizi, Fereidoun, Chadban, Steven J., Chaker, Layal, Dunning, Stephan C., Fox, Caroline, Hirakawa, Yoshihisa, Iseki, Kunitoshi, Ix, Joachim, Jafar, Tazeen H., Koettgen, Anna, Naimark, David M. J., Ohkubo, Takayoshi, Prescott, Gordon J., Rebholz, Casey M., Sabanayagam, Charumathi, Sairenchi, Toshimi, Schoettker, Ben, Shibagaki, Yugo, Tonelli, Marcello, Zhang, Luxia, Gansevoort, Ron T., Matsushita, Kunihiro, Woodward, Mark, Coresh, Josef, Shalev, Varda, Chalmers, John, Arima, Hisatomi, Perkovic, Vlado, Grams, Morgan, Polkinghorne, Kevan, Atkins, Robert, Chadban, Steven, Liu, Lisheng, Zhao, Ming-Hui, Wang, Fang, Wang, Jinwei, Sacks, Frank M., Curhan, Gary C., Shlipak, Michael, Sarnak, Mark J., Katz, Ronit, Hiramoto, Jade, Iso, Hiroyasu, Muraki, Isao, Yamagishi, Kazumasa, Umesawa, Mitsumasa, Brenner, Hermann, Saum, Kai-Uwe, Rothenbacher, Dietrich, Fox, Caroline S., Hwang, Shih-Jen, Chang, Alex R., Green, Jamie, Singh, Gurmukteshwar, Kirchner, H. Lester, Black, Corri, Marks, Angharad, Clark, Laura, Fluck, Nick, Cirillo, Massimo, Hallan, Stein, Ovrehus, Marius, Langlo, Knut Asbjorn, Romundstad, Solfrid, Irie, Fujiko, Correa, Adolfo, Young, Bessie A., Boulware, L. Ebony, Mwasongwe, Stanford, Watanabe, Tsuyoshi, Yamagata, Kunihiro, Asahi, Koichi, Chodick, Gabriel, Sarnak, Mark, Peralta, Carmen, Bottinger, Erwin, Nadkarni, Girish N., Ellis, Stephen B., Nadukuru, Rajiv, Kenealy, Timothy, Elley, C. Raina, Collins, John F., Drury, Paul L., Asayama, Kei, Kikuya, Masahiro, Metoki, Hirohito, Nakayama, Masaaki, Iseki, Chiho, Looker, Helen C., Knowler, William C., Bakker, Stephan J. L., Heerspink, Hiddo J. L., Bernardo, Rancho, Jassal, Simerjot K., Bergstrom, Jaclyn, Ix, Joachim H., Barrett-Connor, Elizabeth, Kovesdy, Csaba P., Sumida, Keiichi, Kalantar-Zadeh, Kamyar, Sedaghat, Sanaz, Ikram, M. Arfan, Hoorn, Ewout J., Dehghan, Abbas, Carrero, Juan J., Evans, Marie, Elinder, Carl-Gustaf, Wettermark, Bjorn, Wong, Tien Y., Cheng, Ching-Yu, Sokor, Riswana Banu Binte Mohamed Abdul, Wen, Chi-Pang, Tsao, Chwen-Keng, Tsai, Min-Kuang, Chen, Chien-Hua, Hosseinpanah, Farhad, Hadaegh, Farzad, Mirbolouk, Mohammadhassan, Solbu, Marit Dahl, Eriksen, Bjorn Odvar, Jenssen, Trond Geir, Eggen, Anne Elise, Lannfelt, Lars, Larsson, Anders, Ärnlöv, Johan, Bilo, Henk J. G., Landman, Gijs W. D., van Hateren, Kornelis J. J., Kleefstra, Nanne, Stempniewicz, Nikita, Cuddeback, John, Ciemins, Elizabeth, Levey, Andrew S., Chen, Jingsha, Kwak, Lucia, Surapeneni, Aditya, Nelson, Robert G., Grams, Morgan E., Ballew, Shoshana H., Sang, Yingying, Azizi, Fereidoun, Chadban, Steven J., Chaker, Layal, Dunning, Stephan C., Fox, Caroline, Hirakawa, Yoshihisa, Iseki, Kunitoshi, Ix, Joachim, Jafar, Tazeen H., Koettgen, Anna, Naimark, David M. J., Ohkubo, Takayoshi, Prescott, Gordon J., Rebholz, Casey M., Sabanayagam, Charumathi, Sairenchi, Toshimi, Schoettker, Ben, Shibagaki, Yugo, Tonelli, Marcello, Zhang, Luxia, Gansevoort, Ron T., Matsushita, Kunihiro, Woodward, Mark, Coresh, Josef, Shalev, Varda, Chalmers, John, Arima, Hisatomi, Perkovic, Vlado, Grams, Morgan, Polkinghorne, Kevan, Atkins, Robert, Chadban, Steven, Liu, Lisheng, Zhao, Ming-Hui, Wang, Fang, Wang, Jinwei, Sacks, Frank M., Curhan, Gary C., Shlipak, Michael, Sarnak, Mark J., Katz, Ronit, Hiramoto, Jade, Iso, Hiroyasu, Muraki, Isao, Yamagishi, Kazumasa, Umesawa, Mitsumasa, Brenner, Hermann, Saum, Kai-Uwe, Rothenbacher, Dietrich, Fox, Caroline S., Hwang, Shih-Jen, Chang, Alex R., Green, Jamie, Singh, Gurmukteshwar, Kirchner, H. Lester, Black, Corri, Marks, Angharad, Clark, Laura, Fluck, Nick, Cirillo, Massimo, Hallan, Stein, Ovrehus, Marius, Langlo, Knut Asbjorn, Romundstad, Solfrid, Irie, Fujiko, Correa, Adolfo, Young, Bessie A., Boulware, L. Ebony, Mwasongwe, Stanford, Watanabe, Tsuyoshi, Yamagata, Kunihiro, Asahi, Koichi, Chodick, Gabriel, Sarnak, Mark, Peralta, Carmen, Bottinger, Erwin, Nadkarni, Girish N., Ellis, Stephen B., Nadukuru, Rajiv, Kenealy, Timothy, Elley, C. Raina, Collins, John F., Drury, Paul L., Asayama, Kei, Kikuya, Masahiro, Metoki, Hirohito, Nakayama, Masaaki, Iseki, Chiho, Looker, Helen C., Knowler, William C., Bakker, Stephan J. L., Heerspink, Hiddo J. L., Bernardo, Rancho, Jassal, Simerjot K., Bergstrom, Jaclyn, Ix, Joachim H., Barrett-Connor, Elizabeth, Kovesdy, Csaba P., Sumida, Keiichi, Kalantar-Zadeh, Kamyar, Sedaghat, Sanaz, Ikram, M. Arfan, Hoorn, Ewout J., Dehghan, Abbas, Carrero, Juan J., Evans, Marie, Elinder, Carl-Gustaf, Wettermark, Bjorn, Wong, Tien Y., Cheng, Ching-Yu, Sokor, Riswana Banu Binte Mohamed Abdul, Wen, Chi-Pang, Tsao, Chwen-Keng, Tsai, Min-Kuang, Chen, Chien-Hua, Hosseinpanah, Farhad, Hadaegh, Farzad, Mirbolouk, Mohammadhassan, Solbu, Marit Dahl, Eriksen, Bjorn Odvar, Jenssen, Trond Geir, Eggen, Anne Elise, Lannfelt, Lars, Larsson, Anders, Ärnlöv, Johan, Bilo, Henk J. G., Landman, Gijs W. D., van Hateren, Kornelis J. J., Kleefstra, Nanne, Stempniewicz, Nikita, Cuddeback, John, Ciemins, Elizabeth, Levey, Andrew S., Chen, Jingsha, Kwak, Lucia, and Surapeneni, Aditya
- Abstract
IMPORTANCE: Early identification of individuals at elevated risk of developing chronic kidney disease (CKD) could improve clinical care through enhanced surveillance and better management of underlying health conditions. OBJECTIVE: To develop assessment tools to identify individuals at increased risk of CKD, defined by reduced estimated glomerular filtration rate (eGFR). DESIGN, SETTING, AND PARTICIPANTS: Individual-level data analysis of 34 multinational cohorts from the CKD Prognosis Consortium including 5 222 711 individuals from 28 countries. Data were collected from April 1970 through January 2017. A 2-stage analysis was performed, with each study first analyzed individually and summarized overall using a weighted average. Because clinical variables were often differentially available by diabetes status, models were developed separately for participants with diabetes and without diabetes. Discrimination and calibration were also tested in 9 external cohorts (n = 2 253 540). EXPOSURES: Demographic and clinical factors. MAIN OUTCOMES AND MEASURES: Incident eGFR of less than 60 mL/min/1.73 m(2). RESULTS: Among 4 441 084 participants without diabetes (mean age, 54 years, 38% women), 660 856 incident cases (14.9%) of reduced eGFR occurred during a mean follow-up of 4.2 years. Of 781 627 participants with diabetes (mean age, 62 years, 13% women), 313 646 incident cases (40%) occurred during a mean follow-up of 3.9 years. Equations for the 5-year risk of reduced eGFR included age, sex, race/ethnicity, eGFR, history of cardiovascular disease, ever smoker, hypertension, body mass index, and albuminuria concentration. For participants with diabetes, the models also included diabetes medications, hemoglobin A(1c), and the interaction between the 2. The risk equations had a median C statistic for the 5-year predicted probability of 0.845 (interquartile range [IQR], 0.789-0.890) in the cohorts without diabetes and 0.801 (IQR, 0.750-0.819) in the cohorts with diabetes. Calib
- Published
- 2019
- Full Text
- View/download PDF
42. Reaching cardiovascular prevention guideline targets with a polypill-based approach : A meta-analysis of randomised clinical trials
- Author
-
Selak, Vanessa, Webster, Ruth, Stepien, Sandrine, Bullen, Chris, Patel, Anushka, Thom, Simon, Arroll, Bruce, Bots, Michiel L., Brown, Alex, Crengle, Sue, Dorairaj, Prabhakaran, Elley, C. Raina, Grobbee, Diederick E., Harwood, Matire, Hillis, Graham S., Laba, Tracey Lea, Neal, Bruce, Peiris, David, Rafter, Natasha, Reid, Christopher, Stanton, Alice, Tonkin, Andrew, Usherwood, Tim, Wadham, Angela, Rodgers, Anthony, Selak, Vanessa, Webster, Ruth, Stepien, Sandrine, Bullen, Chris, Patel, Anushka, Thom, Simon, Arroll, Bruce, Bots, Michiel L., Brown, Alex, Crengle, Sue, Dorairaj, Prabhakaran, Elley, C. Raina, Grobbee, Diederick E., Harwood, Matire, Hillis, Graham S., Laba, Tracey Lea, Neal, Bruce, Peiris, David, Rafter, Natasha, Reid, Christopher, Stanton, Alice, Tonkin, Andrew, Usherwood, Tim, Wadham, Angela, and Rodgers, Anthony
- Published
- 2019
43. Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-analysis of randomised clinical trials
- Author
-
Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epi Team 9, Selak, Vanessa, Webster, Ruth, Stepien, Sandrine, Bullen, Chris, Patel, Anushka, Thom, Simon, Arroll, Bruce, Bots, Michiel L., Brown, Alex, Crengle, Sue, Dorairaj, Prabhakaran, Elley, C. Raina, Grobbee, Diederick E., Harwood, Matire, Hillis, Graham S., Laba, Tracey Lea, Neal, Bruce, Peiris, David, Rafter, Natasha, Reid, Christopher, Stanton, Alice, Tonkin, Andrew, Usherwood, Tim, Wadham, Angela, Rodgers, Anthony, Cardiovasculaire Epi Team 5, Circulatory Health, JC onderzoeksprogramma Cardiovasculaire Epidemiologie, Cardiovasculaire Epi Team 9, Selak, Vanessa, Webster, Ruth, Stepien, Sandrine, Bullen, Chris, Patel, Anushka, Thom, Simon, Arroll, Bruce, Bots, Michiel L., Brown, Alex, Crengle, Sue, Dorairaj, Prabhakaran, Elley, C. Raina, Grobbee, Diederick E., Harwood, Matire, Hillis, Graham S., Laba, Tracey Lea, Neal, Bruce, Peiris, David, Rafter, Natasha, Reid, Christopher, Stanton, Alice, Tonkin, Andrew, Usherwood, Tim, Wadham, Angela, and Rodgers, Anthony
- Published
- 2019
44. Effectiveness of counselling patients on physical activity in general practice: cluster randomised controlled trial. (Primary care)
- Author
-
Elley, C Raina, Kerse, Ngaire, Arroll, Bruce, and Robinson, Elizabeth
- Subjects
Exercise therapy -- Evaluation ,Patient compliance -- Evaluation ,Health ,Evaluation - Abstract
Abstract Objective To assess the long term effectiveness of the 'green prescription' programme, a clinician based initiative in general practice that provides counselling on physical activity. Design Cluster randomised controlled [...]
- Published
- 2003
45. Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium
- Author
-
Inker, Lesley A., primary, Grams, Morgan E., additional, Levey, Andrew S., additional, Coresh, Josef, additional, Cirillo, Massimo, additional, Collins, John F., additional, Gansevoort, Ron T., additional, Gutierrez, Orlando M., additional, Hamano, Takayuki, additional, Heine, Gunnar H., additional, Ishikawa, Shizukiyo, additional, Jee, Sun Ha, additional, Kronenberg, Florian, additional, Landray, Martin J., additional, Miura, Katsuyuki, additional, Nadkarni, Girish N., additional, Peralta, Carmen A., additional, Rothenbacher, Dietrich, additional, Schaeffner, Elke, additional, Sedaghat, Sanaz, additional, Shlipak, Michael G., additional, Zhang, Luxia, additional, van Zuilen, Arjan D., additional, Hallan, Stein I., additional, Kovesdy, Csaba P., additional, Woodward, Mark, additional, Levin, Adeera, additional, Astor, Brad, additional, Appel, Larry, additional, Greene, Tom, additional, Chen, Teresa, additional, Chalmers, John, additional, Arima, Hisatomi, additional, Perkovic, Vlado, additional, Yatsuya, Hiroshi, additional, Tamakoshi, Koji, additional, Li, Yuanying, additional, Hirakawa, Yoshihisa, additional, Matsushita, Kunihiro, additional, Grams, Morgan, additional, Sang, Yingying, additional, Polkinghorne, Kevan, additional, Chadban, Steven, additional, Atkins, Robert, additional, Djurdjev, Ognjenka, additional, Liu, Lisheng, additional, Zhao, Minghui, additional, Wang, Fang, additional, Wang, Jinwei, additional, Ebert, Natalie, additional, Martus, Peter, additional, Tang, Mila, additional, Heine, Gunnar, additional, Emrich, Insa, additional, Seiler, Sarah, additional, Zawada, Adam, additional, Nally, Joseph, additional, Navaneethan, Sankar, additional, Schold, Jesse, additional, Shlipak, Michael, additional, Sarnak, Mark, additional, Katz, Ronit, additional, Hiramoto, Jade, additional, Iso, Hiroyasu, additional, Yamagishi, Kazumasa, additional, Umesawa, Mitsumasa, additional, Muraki, Isao, additional, Fukagawa, Masafumi, additional, Maruyama, Shoichi, additional, Hasegawa, Takeshi, additional, Fujii, Naohiko, additional, Wheeler, David, additional, Emberson, John, additional, Townend, John, additional, Landray, Martin, additional, Brenner, Hermann, additional, Schöttker, Ben, additional, Saum, Kai-Uwe, additional, Fox, Caroline, additional, Hwang, Shih-Jen, additional, Köttgen, Anna, additional, Schneider, Markus P., additional, Eckardt, Kai-Uwe, additional, Green, Jamie, additional, Kirchner, H Lester, additional, Chang, Alex R., additional, Ho, Kevin, additional, Ito, Sadayoshi, additional, Miyazaki, Mariko, additional, Nakayama, Masaaki, additional, Yamada, Gen, additional, Irie, Fujiko, additional, Sairenchi, Toshimi, additional, Yano, Yuichiro, additional, Kotani, Kazuhiko, additional, Nakamura, Takeshi, additional, Kimm, Heejin, additional, Mok, Yejin, additional, Chodick, Gabriel, additional, Shalev, Varda, additional, Wetzels, Jack F.M., additional, Blankestijn, Peter J., additional, van den Brand, Jan, additional, Inker, Lesley, additional, Peralta, Carmen, additional, Kollerits, Barbara, additional, Ritz, Eberhard, additional, Nitsch, Dorothea, additional, Roderick, Paul, additional, Fletcher, Astrid, additional, Bottinger, Erwin, additional, Ellis, Stephen B., additional, Nadukuru, Rajiv, additional, Ueshima, Hirotsugu, additional, Okayama, Akira, additional, Tanaka, Sachiko, additional, Okamura, Tomonori, additional, Kadota, Aya, additional, Kenealy, Timothy, additional, Elley, C Raina, additional, Drury, Paul L., additional, Ohkubo, Takayoshi, additional, Asayama, Kei, additional, Metoki, Hirohito, additional, Kikuya, Masahiro, additional, Nelson, Robert G., additional, Knowler, William C., additional, Bakker, Stephan JL., additional, Hak, Eelco, additional, Heerspink, Hiddo J.L., additional, Brunskill, Nigel, additional, Major, Rupert, additional, Shepherd, David, additional, Medcalf, James, additional, Jassal, Simerjot K., additional, Bergstrom, Jaclyn, additional, Ix, Joachim H., additional, Barrett-Connor, Elizabeth, additional, Kovesdy, Csaba, additional, Kalantar-Zadeh, Kamyar, additional, Sumida, Keiichi, additional, Muntner, Paul, additional, Warnock, David, additional, McClellan, William, additional, de Zeeuw, Dick, additional, Brenner, Barry, additional, Ikram, M Arfan, additional, Hoorn, Ewout J., additional, Dehghan, Abbas, additional, Carrero, Juan J., additional, Gasparini, Alessandro, additional, Wettermark, Björn, additional, Elinder, Carl-Gustaf, additional, Wong, Tien Yin, additional, Sabanayagam, Charumathi, additional, Cheng, Ching-Yu, additional, Visseren, Frank L.J., additional, Evans, Marie, additional, Segelmark, Mårten, additional, Stendahl, Maria, additional, Schön, Staffan, additional, Tangri, Navdeep, additional, Sud, Maneesh, additional, Naimark, David, additional, Wen, Chi-Pang, additional, Tsao, Chwen-Keng, additional, Tsai, Min-Kugng, additional, Chen, Chien-Hua, additional, Konta, Tsuneo, additional, Hirayama, Atsushi, additional, Ichikawa, Kazunobu, additional, Lannfelt, Lars, additional, Larsson, Anders, additional, Ärnlöv, Johan, additional, Bilo, Henk J.G., additional, Landman, Gijs W.D., additional, van Hateren, Kornelis J.J., additional, Kleefstra, Nanne, additional, Coresh (Chair, Josef, additional, Hallan, Stein, additional, Ballew, Shoshana H., additional, Chen, Jingsha, additional, Kwak, Lucia, additional, and Surapaneni, Aditya, additional
- Published
- 2019
- Full Text
- View/download PDF
46. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
- Author
-
Remy, Philippe, Audard, Vincent, Natella, Pierre André, Pelle, Gaëlle, Dussol, Bertrand, Leray-Moragues, Hélène, Bouachi, Khedidja, Dantal, Jacques, Vrigneaud, Laurence, Karras, Alexandre, Pourcine, Frank, Gatault, Philippe, Grimbert, Philippe, Ait Sahlia, Nawelle, Moktefi, Anissa, Daugas, Eric, Rigothier, Claire, Bastuji-Garin, Sylvie, Sahali, Dil, Aldigier, Jean Claude, Bataille, Pierre, Canaud, Bernard, Chauveau, Dominique, Combe, Christian, Choukroun, Gabriel, Cornec-Legall, Emilie, Dahan, Karine, Delahousse, Michel, Desvaux, Dominique, Deteix, Patrice, Durrbach, Antoine, Esnault, Vincent, Essig, Marie, Fievet, Patrick, Frouget, Thierry, Guerrot, Dominique, Godin, Michel, Gontiers-Picard, Annie, Gosselin, Morgane, Hanrotel-Saliou, Catherine, Heng, Anne-Elisabeth, Huart, Antoine, Humbert, Antoine, Kofman, Tomek, Hummel, Aurélie, Lang, Philippe, Laville, Maurice, Lemeur, Yannick, Malvezzi, Paolo, Matignon, Marie, Mesbah, Rafik, Moulin, Bruno, Muller, Sandrine, Olagne, Jerome, Pardon, Agathe, Provôt, François, Queffeulou, Guillaume, Plaisier, Emmanuelle, Raimbourg, Quentin, Rieu, Philippe, Stehlé, Thomas, Vanhille, Philippe, Astor, Brad, Levin, Adeera, Tang, Mila, Djurdjev, Ognjenka, Navaneethan, Sankar, Jolly, Stacey, Schold, Jesse, Nally, Joseph, Emberson, Jonathan, Townend, John, Landray, Martin, Feldman, Harold, Hsu, Chi-Yuan, Lash, James, Appel, Lawrence, Kalra, Philip, Ritchie, James, Maharajan, Raman, Middleton, Rachel, O’donoghue, Donal, Schneider, Markus, Kronenberg, Florian, Bärthlein, Barbara, Green, Jamie, Kirchner, H. Lester, Ho, Kevin, Marks, Angharad, Black, Corri, Prescott, Gordon, Fluck, Nick, Nakayama, Masaaki, Miyazaki, Mariko, Yamamoto, Tae, Yamada, Gen, Wang, Angela Yee-Moon, Cheung, Sharon, Wong, Sharon, Chu, Jessie, Wu, Henry, Garg, Amit, Mcarthur, Eric, Nash, Danielle, Shalev, Varda, Chodick, Gabriel, Blankestijn, Peter, Wetzels, Jack F.M., van Zuilen, Arjan, van den Brand, Jan, Inker, Lesley, Sarnak, Mark, Tighiouart, Hocine, Zhang, Haitao, Stengel, Bénédicte, Metzger, Marie, Flamant, Martin, Houillier, Pascal, Haymann, Jean-Philippe, Rios, Pablo, Mazzuchi, Nelson, Gadola, Liliana, Lamadrid, Verónica, Solá, Laura, Collins, John, Elley, C. Raina, Kenealy, Timothy, Moranne, Olivier, Couchoud, Cécile, Vigneau, Cécile, Brunskill, Nigel, Major, Rupert, Shepherd, David, Medcalf, James, Kovesdy, Csaba, Kalantar-Zadeh, Kamyar, Sumida, Keiichi, Potukuchi, Praveen, Heerspink, Hiddo J.L., de Zeeuw, Dick, Brenner, Barry, Carrero, Juan Jesus, Gasparini, Alessandro, Qureshi, Abdul Rashid, Elinder, Carl-Gustaf, Visseren, Frank L.J., van Der Graaf, Yolanda, Evans, Marie, Stendahl, Maria, Schön, Staffan, Segelmark, Mårten, Prütz, Karl-Göran, Naimark, David, Tangri, Navdeep, Mark, Patrick, Traynor, Jamie, Geddes, Colin, Thomson, Peter, Chang, Alex, Gansevoort, Ron, Köttgen, Anna, Levey, Andrew, Zhang, Luxia, Ballew, Shoshana, Chen, Jingsha, Coresh, Josef, Grams, Morgan, Kwak, Lucia, Matsushita, Kunihiro, Sang, Yingying, Surapaneni, Aditya, Woodward, Mark, Eckardt, Kai-Uwe, Hemmelgarn, Brenda, Wheeler, David, Winkelmayer, Wolfgang, Davis, John, Green, Danielle, Cheung, Michael, Green, Tanya, Mcmahan, Melissa, Molnar, Miklos, Service de néphrologie [CHU Henri Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor, Assistance Publique-Hôpitaux de Paris, Department of Pathology, Centre hospitalier universitaire Henri Mondor, F-94000 Créteil, France, Department of Nephrology and Transplantation, Foch Hospital, Chirurgie urologique et transplantation rénale [Hôpital de la Conception - APHM], Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service de néphrologie et transplantation, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Transplantation Urologie et Néphrologie, Centre hospitalier universitaire de Nantes (CHU Nantes), Service de Néphrologie [Valenciennes], Centre Hospitalier de Valenciennes, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Service de Néphrologie CHU TOURS, INSERM U955, équipe 21, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), UMR 1599, Centre National de la Recherche Scientifique (CNRS), Department of Nephrology, Transplantation and Dialysis, Bordeaux, Laboratoire d'Investigation Clinique (LIC), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Henri Mondor, Université de Lausanne = University of Lausanne (UNIL), Service de Néphrologie et Immunopathologie Clinique, Centre Hospitalier Universitaire de Toulouse, PRES Université de Toulouse, CHU Bordeaux [Bordeaux], Unité Médicale de Soins Intensifs, CHU Amiens-Picardie, CHRU Brest - Service de Nephrologie (CHU - BREST - Nephrologie), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Service de Département de Néphrologie = Service de Néphrologie et Dialyses [CHU Tenon], CHU Tenon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de transplantation rénale, Hôpital Foch [Suresnes], Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service Néphrologie, Pôle REUNNIRH, CHU Clermont-Ferrand, U542, Institut National de la Santé et de la Recherche Médicale (INSERM), Service de néphrologie, Centre Hospitalier Universitaire de Nice (CHU Nice), Service de Néphrologie, Dialyse, Transplantations [CHU Limoges], CHU Limoges, Univers, Transport, Interfaces, Nanostructures, Atmosphère et environnement, Molécules (UMR 6213) (UTINAM), Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), CHU Pontchaillou [Rennes], Service de Néphrologie [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU), Nouvelles Cibles Pharmacologiques de la Protection Endothéliale et de l'Insuffisance Cardiaque (EnVI), Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Néphrologie, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Hôpital de la Cavale Blanche - CHRU Brest (CHU - BREST ), Unité de Nutrition Humaine (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020]), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), Service de néphrologie, dialyse, aphérèses et transplantation, CHU Grenoble-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), CH Boulogne sur Mer, Service de Néphrologie et Transplantation, CHU Strasbourg, CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Néphrologie [CHPC - Site Louis Pasteur], Site Louis Pasteur [CHPC], CH Centre Hospitalier Public du Cotentin (CHPC)-CH Centre Hospitalier Public du Cotentin (CHPC), Remodelage et Reparation du Tissu Renal, Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Néphrologie [Bichat - Claude Bernard], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Centre Hospitalier Universitaire de Reims (CHU Reims), Université Paris Descartes - Faculté de Médecine (UPD5 Médecine), Université Paris Descartes - Paris 5 (UPD5), Service de médecine interne et néphrologie, CH Valenciennes, Division of Nephrology [Vancouver, BC, Canada], University of British Columbia (UBC), Aberdeen University, Fraunhofer Institute for Secure Information Technology [Darmstadt] (Fraunhofer SIT), Fraunhofer (Fraunhofer-Gesellschaft), Division of genetic epidemiology, HMNC Brain Health-Molecular and Clinical Pharmacology-Innsbruck Medical University [Austria] (IMU), Department of electronic engineering, Chang Gung University, Institute of Applied Health Sciences, University of Aberdeen, Department of Medicine, The University of Hong Kong (HKU), Department of Nephrology [Utrecht, Pays-Bas], University Medical Center [Utrecht], Department of Nephrology [Nijmegen, The Netherlands], Radboud University Medical Center [Nijmegen], Department of nephrology [Nimègue, Pays-Bas], Radboud Institute for Health Sciences [Nimègue, Pays-Bas], Radboud University Medical Center [Nijmegen]-Radboud University Medical Center [Nijmegen], Tufts Medical Center, Nanjing University of Aeronautics and Astronautics [Nanjing] (NUAA), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Physiologie [Bichat-Claude Bernard], Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Service de Physiologie [Georges-Pompidou], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5), Des Maladies Rénales Rares aux Maladies Fréquentes, Remodelage et Réparation, Center for Research in Agricultural Genomics, Directora Division Epidemiologia [Montevideo, Uruguay], Ministerio de Salud Publica, Hôpital Pasteur [Nice] (CHU)-Centre Hospitalier Universitaire de Nice (CHU Nice), Agence de la biomédecine [Saint-Denis la Plaine], Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Division of Nephrology, Department of Medicine, Vanderbilt University School of Medicine [Nashville], Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet [Stockholm], Julius Center for Health Sciences and Primary Care, Division of Drug Research/Clinical Pharmacology, Department of Medicine and Health, Faculty of Health Sciences, Linköping University (LIU), Department of Nephrology [Groningue, Pays-Bas], University Medical Center Groningen [Groningen] (UMCG), Renal Division [Beijing, China], Peking University [Beijing], The Georges Institute for International Health, The University of Sydney, Department of Nephrology and Hypertension [Erlangen, Germany], Friedrich-Alexander Universität Erlangen-Nürnberg (FAU), Baylor College of Medicine (BCM), Baylor University, Université de Lausanne (UNIL), Service de Néphrologie et Dialyses [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-CHU Rouen, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble, Service de néphrologie [CHPC, Cherbourg-en-Cotentin], CHPC - Site Louis Pasteur, Centre Hospitalier Public du Cotentin (CHPC)-Centre Hospitalier Public du Cotentin (CHPC), Innsbruck Medical University [Austria] (IMU)-HMNC Brain Health-Molecular and Clinical Pharmacology, Radboud University Medical Centre [Nijmegen, The Netherlands], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )-Institut National de la Santé et de la Recherche Médicale (INSERM)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Université d'Angers (UA), Peking University First Hospital [China]-Peking University Institute of Nephrology [China], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor [Créteil], Service Médecine interne et immunopathologie clinique [CHU Toulouse], Pôle IUCT [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), HMNC Brain Health-Molecular and Clinical Pharmacology-Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Henri Mondor, Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Conception [CHU - APHM] (LA CONCEPTION ), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut Mondor de Recherche Biomédicale (IMRB), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Tenon [APHP], Centre Hospitalier Universitaire de Clermont-Ferrand, Université de Rouen Normandie (UNIROUEN), Unité de Nutrition Humaine - Clermont Auvergne (UNH), Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne (UCA), Service de Néphrologie, Dialyse, Aphérèses et Transplantation [CHU Grenoble], Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Saint-Antoine [APHP], Centre Hospitalier du Cotentin, Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 (UPD7), Fraunhofer Institute for Secure Information Technology [Darmstadt] (SIT), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Université Paris Descartes - Paris 5 (UPD5), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Méthodes Algorithmes pour l'Ordonnancement et les Réseaux (MAORE), Laboratoire d'Informatique de Robotique et de Microélectronique de Montpellier (LIRMM), and Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Nephrology ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,media_common.quotation_subject ,030232 urology & nephrology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,In patient ,030212 general & internal medicine ,mycophenolate ,media_common ,clinical trial ,Art ,medicine.disease ,Optimal management ,Treatment efficacy ,3. Good health ,Transplantation ,Cohort ,idiopathic nephrotic syndrome ,Humanities ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,steroids ,Kidney disease ,Cohort study - Abstract
The Chronic Kidney Disease (CKD) Prognosis Consortium is a collaborative author of the above-mentioned article. The CKD Prognosis Consortium investigators/collaborators are as follows: • African American Study of Kidney Disease and Hypertension (AASK): Brad Astor, Lawrence J. Appel; Canadian Study of Prediction of Death, Dialysis and Interim Cardiovascular Events (CanPREDDICT): Adeera Levin, Mila Tang, Ognjenka Djurdjev; Cleveland Clinic CKD Registry Study (CCF): Sankar D. Navaneethan, Stacey E. Jolly, Jesse D. Schold, Joseph V. Nally Jr.; Chronic Renal Impairment in Birmingham (CRIB): David C. Wheeler, Jonathan Emberson, John Townend, Martin Landray; Chronic Renal Insufficiency Cohort Study (CRIC): Harold I. Feldman, Chi-yuan Hsu, James P. Lash, Lawrence J. Appel; Chronic Renal Insufficiency Standards Implementation Study (CRISIS): Philip A. Kalra, James P. Ritchie, Raman Maharajan, Rachel J. Middleton, Donal J. O'Donoghue; German Chronic Kidney Disease Study (GCKD): Kai-Uwe Eckardt, Markus P. Schneider, Anna Kottgen, Florian Kronenberg, Barbara Barthlein; Geisinger Health System: Alex R. Chang, Jamie A. Green, H. Lester Kirchner, Kevin Ho; Grampian Laboratory Outcomes, Morbidity and Mortality Studies – 2 (GLOMMS2): Angharad Marks, Corri Black, Gordon J. Prescott, Nick Fluck; Gonryo Study: Masaaki Nakayama, Mariko Miyazaki, Tae Yamamoto, Gen Yamada; Hong Kong CKD Studies: Angela Yee-Moon Wang, Sharon Cheung, Sharon Wong, Jessie Chu, Henry Wu; Ontario Institute for Clinical Evaluative Sciences, Provincial Kidney, Dialysis and Transplantation program (ICES KDT): Amit X. Garg, Eric McArthur, Danielle M. Nash; Maccabi Health System: Varda Shalev, Gabriel Chodick; Multifactorial Approach and Superior Treatment Efficacy in Renal Patients with the Aid of a Nurse Practitioner (MASTERPLAN): Peter J. Blankestijn, Jack F.M. Wetzels, Arjan D. van Zuilen, Jan A. van den Brand; Modification of Diet in Renal Disease Study (MDRD): Andrew S. Levey, Lesley A. Inker, Mark J. Sarnak, Hocine Tighiouart; Nanjing CKD Network Cohort Study (Nanjing CKD): Haitao Zhang; NephroTest Study (NephroTest): Benedicte Stengel, Marie Metzger, Martin Flamant, Pascal Houillier, Jean-Philippe Haymann; National Renal Healthcare Program – Uruguay (NRHP-URU): Pablo G. Rios, Nelson Mazzuchi, Liliana Gadola, Veronica Lamadrid, Laura Sola; New Zealand Diabetes Cohort Study (NZDCS): John F. Collins, C. Raina Elley, Timothy Kenealy; Parcours de Soins des Personnes Agees (PSPA): Olivier Moranne, Cecile Couchoud, Cecile Vigneau; Primary-Secondary Care Partnership to Prevent Adverse Outcomes in Chronic Kidney Disease (PSP CKD): Nigel J. Brunskill, Rupert W. Major, David Shepherd, James F. Medcalf; Racial and Cardiovascular Risk Anomalies in CKD Cohort (RCAV): Csaba P. Kovesdy, Kamyar Kalantar-Zadeh, Miklos Z. Molnar, Keiichi Sumida, Praveen K. Potukuchi; Reduction of Endpoints in Non-insulin Dependent Diabetes Mellitus with the Angiotensin II Antagonist Losartan (RENAAL): Hiddo J.L. Heerspink, Dick de Zeeuw, Barry Brenner; Stockholm CREAtinine Measurements Cohort (SCREAM): Juan Jesus Carrero, Alessandro Gasparini, Abdul Rashid Qureshi, Carl-Gustaf Elinder; Second Manifestations of ARTerial Disease Study (SMART): Frank L.J. Visseren, Yolanda van der Graaf; Swedish Renal Registry CKD Cohort (SRR CKD): Marie Evans, Maria Stendahl, Staffan Schon, Marten Segelmark, Karl-Goran Prutz; Sunnybrook Cohort: David M. Naimark, Navdeep Tangri; West of Scotland CKD Study: Patrick B. Mark, Jamie P. Traynor, Colin C. Geddes, Peter C. Thomson.• CKD Prognosis Consortium Steering Committee: Alex R. Chang, Josef Coresh (Chair), Ron T. Gansevoort, Morgan E. Grams, Anna Kottgen, Andrew S. Levey, Kunihiro Matsushita, Mark Woodward, Luxia Zhang.• CKD Prognosis Consortium Data Coordinating Center: Shoshana H. Ballew (Assistant Project Director), Jingsha Chen (Programmer), Josef Coresh (Principal Investigator), Morgan E. Grams (Director of Nephrology Initiatives), Lucia Kwak (Programmer), Kunihiro Matsushita (Director), Yingying Sang (Lead Programmer), Aditya Surapaneni (Programmer), Mark Woodward (Senior Statistician).• Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference on Prognosis and Optimal Management of Patients with Advanced CKD: Kai-Uwe Eckardt (Conference Co-Chair), Brenda R. Hemmelgarn (Conference Co-Chair), David C. Wheeler (KDIGO Co-Chair), Wolfgang C. Winkelmayer (KDIGO Co-Chair), John Davis (CEO), Danielle Green (Managing Director), Michael Cheung (Chief Scientific Officer), Tanya Green (Communications Director), Melissa McMahan (Programs Director).
- Published
- 2018
47. DeLLITE Depression in late life: an intervention trial of exercise. Design and recruitment of a randomised controlled trial
- Author
-
Keeling Sally, Peri Kathy, Hatcher Simon, Elley C Raina, Dowell Tony, Kolt Gregory S, Hayman Karen J, Moyes Simon A, Falloon Karen, Kerse Ngaire, Robinson Elizabeth, Parsons John, Wiles Janine, and Arroll Bruce
- Subjects
Geriatrics ,RC952-954.6 - Abstract
Abstract Background Physical activity shows potential in combating the poor outcomes associated with depression in older people. Meta-analyses show gaps in the research with poor trial design compromising certainty in conclusions and few programmes showing sustained effects. Methods/design The Depression in Late Life: an Intervention Trial of Exercise (DeLLITE) is a 12 month randomised controlled trial of a physical activity intervention to increase functional status in people aged 75 years and older with depressive symptoms. The intervention involves an individualised activity programme based on goal setting and progression of difficulty of activities delivered by a trained nurse during 8 home visits over 6 months. The control group received time matched home visits to discuss social contacts and networks. Baseline, 6 and 12 months measures were assessed in face to face visits with the primary outcome being functional status (SPPB, NEADL). Secondary outcomes include depressive symptoms (Geriatric Depression Scale), quality of life (SF-36), physical activity (AHS Physical Activity Questionnaire) and falls (self report). Discussion Due to report in 2008 the DeLLITE study has recruited 70% of those eligible and tests the efficacy of a home based, goal setting physical activity programme in improving function, mood and quality of life in older people with depressive symptomatology. If successful in improving function and mood this trial could prove for the first time that there are long term health benefit of physical activity, independent of social activity, in this high risk group who consume excess health related costs. Trial registration Australian and New Zealand Clinical Trials Register ACTRN12605000475640
- Published
- 2008
- Full Text
- View/download PDF
48. The 'Women's Lifestyle Study', 2-year randomized controlled trial of physical activity counselling in primary health care: rationale and study design
- Author
-
Dowell Anthony C, Elley C Raina, Lawton Beverley A, Rose Sally B, and Fenton Anna J
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Physical inactivity is an independent risk factor for diabetes and heart disease. There is evidence that increasing physical activity can reduce the risk of developing these chronic diseases, but less evidence about effective ways to increase adherence to physical activity. Interventions are therefore needed that produce sustained increases in adherence to physical activity, are cost-effective and improve clinical endpoints. Methods The Women's Lifestyle Study is a two year randomized controlled trial involving a nurse-led intervention to increase physical activity in 40–74 year old physically inactive women recruited from primary care. Baseline measures were assessed in a face-to-face interview with a primary care nurse. The intervention involved delivery of a 'Lifestyle script' by a primary care nurse followed by telephone counselling for nine months and a face-to-face nurse visit at six months. Outcome measurements are assessed at 12 and 24 months. The primary outcome is physical activity measured using a validated physical activity questionnaire. Secondary outcomes include blood pressure, weight, waist circumference, physical fitness (step test), serum HbA1c, fasting glucose, lipids, insulin, and quality of life (SF36). Costs were measured prospectively to allow a subsequent cost-effectiveness evaluation if the trial is positive. Discussion Due to report in 2008, the Women's Lifestyle Study tests the effectiveness of an enhanced low-cost, evidence-based intervention in increasing physical activity, and improving cardiovascular and diabetes risk indicators over two years. If successful in demonstrating improvements in health outcomes, this randomized controlled trial will be the first to demonstrate long-term cardiovascular and diabetes risk health benefit, in addition to improvements in physical activity, from a sustainable physical activity intervention based in primary care. Trial Registration Australian Clinical Trials Registry (ACTR), ACTRN012605000490673.
- Published
- 2007
- Full Text
- View/download PDF
49. Falls Assessment Clinical Trial (FACT): design, interventions, recruitment strategies and participant characteristics
- Author
-
Lawton Beverley, McKinlay Eileen, Garrett Sue, Kerse Ngaire M, Robertson M Clare, Elley C Raina, Moriarty Helen, and Campbell A John
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Guidelines recommend multifactorial intervention programmes to prevent falls in older adults but there are few randomised controlled trials in a real life health care setting. We describe the rationale, intervention, study design, recruitment strategies and baseline characteristics of participants in a randomised controlled trial of a multifactorial falls prevention programme in primary health care. Methods Participants are patients from 19 primary care practices in Hutt Valley, New Zealand aged 75 years and over who have fallen in the past year and live independently. Two recruitment strategies were used – waiting room screening and practice mail-out. Intervention participants receive a community based nurse assessment of falls and fracture risk factors, home hazards, referral to appropriate community interventions, and strength and balance exercise programme. Control participants receive usual care and social visits. Outcome measures include number of falls and injuries over 12 months, balance, strength, falls efficacy, activities of daily living, quality of life, and physical activity levels. Results 312 participants were recruited (69% women). Of those who had fallen, 58% of people screened in the practice waiting rooms and 40% when screened by practice letter were willing to participate. Characteristics of participants recruited using the two methods are similar (p > 0.05). Mean age of all participants was 81 years (SD 5). On average participants have 7 medical conditions, take 5.5 medications (29% on psychotropics) with a median of 2 falls (interquartile range 1, 3) in the previous year. Conclusion The two recruitment strategies and the community based intervention delivery were feasible and successful, identifying a high risk group with multiple falls. Recruitment in the waiting room gave higher response rates but was less efficient than practice mail-out. Testing the effectiveness of an evidence based intervention in a 'real life' setting is important. Trial registration Australian Clinical Trials Register ID 12605000054617.
- Published
- 2007
- Full Text
- View/download PDF
50. Pedometers and text messaging to increase physical activity: randomized controlled trial of adolescents with type 1 diabetes
- Author
-
Newton, Kirsty H., Wiltshire, Esko J., and Elley, C. Raina
- Subjects
Exercise -- Surveys -- Research ,Diabetes therapy -- Surveys -- Research ,Text messaging -- Surveys -- Research ,Diabetes -- Research ,Physical fitness -- Surveys -- Research ,Health ,Text messaging ,Diseases ,Research ,Surveys - Abstract
OBJECTIVE--To assess whether pedometers and text messaging increase physical activity in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS--A 12-week randomized controlled trial was conducted. A total of 78 [...]
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.